7 reports

Immunotoxicity of monoclonal antibodies. mAbs; ##(##): ##-## Duan C, et al. (2015).

  • Medical Biotechnology
  • Monoclonal Antibody
  • AbbVie Inc.
  • Genmab group
  • Johnson & Johnson
  • BASIC INFORMATION
  • NEWS AROUND DARZALEX

It is the first monoclonal antibody used for treating multiple myeloma.

  • Monoclonal Antibody
  • Therapy
  • United States
  • Demand
  • Genmab group
  • ARZERRA - DRUG PROFILE
  • GALIXIMAB (ANTI-CD80 MAB; BIOGEN IDEC)

Lin TS (2010) Ofatumumab: a novel monoclonal anti-CD## antibody.

  • Monoclonal Antibody
  • European Union
  • Japan
  • United States
  • Genmab group
  • Genmab Enters into Licensing Agreement with Janssen Biotech for Daratumumab
  • ASSET PURCHASE

Its omnirat is an antibody platform that generates human monoclonal antibodies based on transgenic rats.

  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • Company Financials
  • Genmab group

RITUXAN / MABTHERA BIOSIMILAR ANTIBODIES - ##/ ## 2093 ## ID No.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Biogen Idec Inc.
  • Boehringer Ingelheim GmbH
  • Genmab group
  • Deal Rationale
  • Other Significant Developments

Deal Rationale Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer.

  • Monoclonal Antibody
  • Therapy
  • United States
  • Company Financials
  • Genmab group
  • MONOCLONAL ANTIBODY 1 FOR CENTRAL NERVOUS SYSTEM DISORDERS
  • MONOCLONAL ANTIBODY 3 FOR CENTRAL NERVOUS SYSTEM DISORDERS

It is a monoclonal antibody.

  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • United States
  • Genmab group